Problems and Controversies in the Diagnosis of Barrett’s Esophagus and Barrett’s-Related Adenocarcinoma
- Lecture / Round table discussion on Barrett’s esophagus, its definition, and its implications
Date and Time: Saturday, March 21, 2015, 3:00 – 5:00PM
Location: Hynes Convention Center, Room 302
Moderator: Hala El-Zimaity, University of Toronto, Toronto, ON, Canada.
3 – 3: 05PM: Welcome / Education Committee / Outline of Expectations for Round Table
3:3 05 – 3: 035PM: Clinical definition of Barrett’s, its impact on cancer prevention: Richard Rothstein, Chief of Gastro and Chair of Medicine at Dartmouth’s Geisel School of Medicine
3: 35 – 4: 05PM: The definition of Barrett’s that Requires the presence of goblet cells appropriately prevents cardia and Barrett’s related esophageal cancer: John Hart, Director, Gastrointestinal Pathology Fellowship, The University of Chicago
4: 05 – 4: 35PM: The definition of Barrett’s that does not require the presence of goblet cells decreases cardia cancer as well as Barrett’s related esophageal cancer, Michael Vieth, Professor, Institute of Pathology, Bayreuth, Germany
4:45 – 5:00PM. Questions and Discussions
Unlike many courses, the goal of this forum is to discuss controversial issues in gastrointestinal pathology. This forum is on Barrett’s related adenocarcinoma. Although each speaker will have a different take on the topic, each speaker will address: 1. Why most patients with Barrett’s related adenocarcinoma as well as adenocarcinoma of the cardia present with the disease and not in any screening program; 2. How would they classify an esophageal tongue, Prague C3, M5? Should the surveillance be different with or without identifying goblets; 3. What do you call glandular epithelium with no goblets in kids?